(Q26743390)

English

Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice

scientific article

In more languages

Statements

scholarly article

0 references

6 references

12 March 2019

21 March 2019

28 September 2019

3 October 2019

14 September 2020

28 January 2021

Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice (English)

0 references

5 references

12 March 2019

21 March 2019

28 September 2019

3 October 2019

14 September 2020

1 reference

28 September 2019

1 reference

14 September 2020

Serine/threonine-protein kinase TOR

1 reference

28 January 2021

1 reference

based on heuristic

inferred from title

3

object named as

Hope S Rugo

0 references

Joyce O'Shaughnessy

2

object named as

Joyce A O'Shaughnessy

0 references

author name string

Douglas E Peterson

1

0 references

Sharon Elad

4

0 references

Mark M Schubert

5

0 references

Chi T Viet

6

0 references

Cynthia Campbell-Baird

7

0 references

Jan Hronek

8

0 references

Virginia Seery

9

0 references

Josephine Divers

10

0 references

John Glaspy

11

0 references

Brian L Schmidt

12

0 references

Timothy F Meiller

13

0 references

language of work or name

0 references

publication date

August 2016

0 references

1 August 2016

6 references

12 March 2019

21 March 2019

28 September 2019

3 October 2019

14 September 2020

28 January 2021

Cancer Medicine

7 references

12 March 2019

21 March 2019

28 September 2019

3 October 2019

14 September 2020

28 January 2021

5

0 references

8

0 references

1897-907

0 references

copyright license

Creative Commons Attribution

6 references

12 March 2019

21 March 2019

28 September 2019

3 October 2019

14 September 2020

28 January 2021

copyright status

0 references

on focus list of Wikimedia project

0 references

Mammalian target of rapamycin inhibitor-associated stomatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

7 April 2017

Pharmacotherapy for adverse events reduces the length of hospital stay in patients admitted to otolaryngology ward: a single arm intervention study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

7 April 2017

Recognition and Management of Oral Mucosal Injury Caused by Mammalian Target of Rapamycin Inhibitors: A Case Series

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

The oral microbiota of patients with recurrent aphthous stomatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Mucosal microbiome in patients with recurrent aphthous stomatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Adverse event management of mTOR inhibitors during treatment of hormone receptor-positive advanced breast cancer: considerations for oncologists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Review of preclinical studies on treatment of mucositis and associated pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Risk of mucocutaneous toxicities in patients with solid tumors treated with sorafenib: an updated systematic review and meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

New frontiers in mucositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Inhibition of caspases protects mice from radiation-induced oral mucositis and abolishes the cleavage of RNA-binding protein HuR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Irinotecan disrupts tight junction proteins within the gut : implications for chemotherapy-induced gut toxicity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Recurrent aphthous stomatitis: genetic aspects of etiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Oral mucosal injury caused by cancer therapies: current management and new frontiers in research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Oral mucosal injury in oncology patients: perspectives on maturation of a field

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Phase I study of vinblastine and sirolimus in pediatric patients with recurrent or refractory solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Immune responses of macrophages and dendritic cells regulated by mTOR signalling.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

SNP-based Bayesian networks can predict oral mucositis risk in autologous stem cell transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Oral mucositis in head and neck cancer: risk, biology, and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Emerging evidence on the pathobiology of mucositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Use of archived biopsy specimens to study gene expression in oral mucosa from chemotherapy-treated cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

A review of oral toxicity associated with mTOR inhibitor therapy in cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Everolimus in the treatment of hormone receptor-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Oral complications of cancer and cancer therapy: from cancer treatment to survivorship

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Managing stomatitis in patients treated with Mammalian target of rapamycin inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Management of cancer therapy-induced oral mucositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Clinical presentation and management of mTOR inhibitor-associated stomatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Oral complications of targeted cancer therapies: a narrative literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Reduced dietary intake of vitamin B12 and folate in patients with recurrent aphthous stomatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

A deletion polymorphism in glutathione-S-transferase mu (GSTM1) and/or theta (GSTT1) is associated with an increased risk of toxicity after autologous blood and marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Mucositis: The impact, biology and therapeutic opportunities of oral mucositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Updated clinical practice guidelines for the prevention and treatment of mucositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Clinical practice. Aphthous ulceration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Safety and pharmacokinetics of escalated doses of weekly intravenous infusion of CCI-779, a novel mTOR inhibitor, in patients with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

The pathobiology of mucositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 September 2017

Mammalian target of rapamycin inhibitor-associated stomatitis in hematopoietic stem cell transplantation patients receiving sirolimus prophylaxis for graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

31 May 2018

Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

31 May 2018

Incidence and risk factors of oral mucositis in paediatric and adolescent patients undergoing chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCAM4.761

21 January 2018

Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

1 reference

https://api.crossref.org/works/10.1002%2FCAM4.761

21 January 2018

Stomatitis Associated With Use of mTOR Inhibitors: Implications for Patients With Invasive Breast Cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCAM4.761

21 January 2018

Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis.

1 reference

https://api.crossref.org/works/10.1002%2FCAM4.761

21 January 2018

Impact of haematologic deficiencies on recurrent aphthous ulceration: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCAM4.761

21 January 2018

Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel

1 reference

https://api.crossref.org/works/10.1002%2FCAM4.761

21 January 2018

Natural history, management and pharmacokinetics of everolimus-induced-oral ulcers: insights into compliance issues.

1 reference

https://api.crossref.org/works/10.1002%2FCAM4.761

21 January 2018

Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4971919

28 November 2018

Recurrent aphthous stomatitis: investigation of possible etiologic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/27334013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clobetasol ameliorates aphthous ulceration in renal transplant patients on sirolimus

1 reference

https://pubmed.ncbi.nlm.nih.gov/27334013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/27334013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The MASCC/ISOO Mucositis Guidelines Update: introduction to the first set of articles

1 reference

https://pubmed.ncbi.nlm.nih.gov/27334013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

mTOR inhibitor-associated stomatitis (mIAS) in three patients with cancer treated with everolimus

1 reference

https://pubmed.ncbi.nlm.nih.gov/27334013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TLR2, TLR4 and CD86 gene polymorphisms in recurrent aphthous stomatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27334013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26743390&oldid=1651649788"